Erin Henitz, BS
Erin Henitz, BS
Dr
Janssen Research & Development
920 Toute 202, Raritan
Raritan,
NJ
USA
08869
Papers:
99 - Featured Poster
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in subjects with advanced ovarian cancer: exploratory analysis of phase III OVA-301 study